In thrombin stimulated human platelets Citalopram, Promethazine, Risperidone, and Ziprasidone, but not Diazepam, may exert their pharmacological effects also through intercalation in membrane phospholipids in a receptor-independent manner

[1]  A. Lund,et al.  An intercalation mechanism as a mode of action exerted by psychotropic drugs: results of altered phospholipid substrate availabilities in membranes? , 2010, Journal of chemical biology.

[2]  B. Baldetorp,et al.  Demonstration of histamine receptors on human platelets by flow cytometry. , 2009, Scandinavian journal of haematology.

[3]  B. Olas,et al.  The changes of aggregability of blood platelets in schizophrenia , 2009, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[4]  E. Hodneland,et al.  Psychotropic drugs interfere with the tight coupling of polyphosphoinositide cycle metabolites in human platelets: a result of receptor-independent drug intercalation in the plasma membrane? , 2008, Biochimica et biophysica acta.

[5]  H. Holmsen,et al.  Effects of psychotropic drugs on the thrombin-induced liberation of arachidonate in human platelets. , 2008, Saudi medical journal.

[6]  J. Gates,et al.  Benzodiazepines in epilepsy: pharmacology and pharmacokinetics , 2008, Acta neurologica Scandinavica.

[7]  P. Bugert,et al.  The dopamine agonism on ADP-stimulated platelets is mediated through D2-like but not D1-like dopamine receptors , 2008, Naunyn-Schmiedeberg's Archives of Pharmacology.

[8]  H. Gjerde,et al.  The psychotropic drug olanzapine (Zyprexa) increases the area of acid glycerophospholipid monolayers. , 2008, Biophysical chemistry.

[9]  S. Kee,et al.  Adaptation of the OODA Loop to reduce postoperative nausea and vomiting in a high-risk outpatient oncology population. , 2008, Journal of perianesthesia nursing : official journal of the American Society of PeriAnesthesia Nurses.

[10]  H. Arai,et al.  Maximal Response to Electroconvulsive Therapy for the Treatment of Catatonic Symptoms , 2007, The journal of ECT.

[11]  P. Sheehan.  Hyperemesis gravidarum--assessment and management. , 2007, Australian family physician.

[12]  T. Lindahl,et al.  IN VITRO EFFECTS OF ANTIPSYCHOTICS ON HUMAN PLATELET ADHESION AND AGGREGATION AND PLASMA COAGULATION , 2007, Clinical and experimental pharmacology & physiology.

[13]  L. Citrome,et al.  Ziprasidone for schizophrenia and bipolar disorder: a review of the clinical trials. , 2007, CNS drug reviews.

[14]  T. Holmøy,et al.  [A stiff-legged man with a bizarre gait]. , 2007, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

[15]  Kristi J. Craft,et al.  First-generation H1 antihistamines found in pilot fatalities of civil aviation accidents, 1990-2005. , 2007, Aviation, space, and environmental medicine.

[16]  A. Kyritsis,et al.  Patient Compliance With SSRIs and Gabapentin in Painful Diabetic Neuropathy , 2007, The Clinical journal of pain.

[17]  H. Holmsen,et al.  Trifluoperazine causes a disturbance in glycerophospholipid monolayers containing phosphatidylserine (PS): effects of pH, acyl unsaturation, and proportion of PS. , 2007, Langmuir : the ACS journal of surfaces and colloids.

[18]  D. Atar,et al.  Escitalopram, but Not Its Major Metabolites, Exhibits Antiplatelet Activity in Humans , 2006, Journal of clinical psychopharmacology.

[19]  Tiao-Lai Huang.  Lorazepam and diazepam rapidly relieve catatonic signs in patients with schizophrenia , 2005, Psychiatry and clinical neurosciences.

[20]  S. Stahl,et al.  Atypical Antipsychotics: Matching Receptor Profile to Individual Patient's Clinical Profile , 2004, CNS Spectrums.

[21]  A. Greenspan,et al.  In vitro effects of risperidone and 9-hydroxy-risperidone on human platelet function, plasma coagulation, and fibrinolysis. , 2004, Clinical therapeutics.

[22]  Pal Pacher,et al.  Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns? , 2004, Current pharmaceutical design.

[23]  H. Holmsen,et al.  Chlorpromazine interaction with phosphatidylserines: a (13)C and (31)P solid-state NMR study. , 2004, Biochimica et biophysica acta.

[24]  J. Jaffe,et al.  A postmarketing study of relative abuse liability of hypnotic sedative drugs. , 2004, Addiction.

[25]  I. Weiner,et al.  Disruption and Potentiation of Latent Inhibition by Risperidone: The Latent Inhibition Model of Atypical Antipsychotic Action , 2003, Neuropsychopharmacology.

[26]  M. Atmaca,et al.  The efficacy of citalopram in the treatment of premature ejaculation: a placebo-controlled study , 2002, International Journal of Impotence Research.

[27]  T. Dinan,et al.  Elevated expression of integrin αIIb βIIIa in drug-naïve, first-episode schizophrenic patients , 2002, Biological Psychiatry.

[28]  H. Verschueren,et al.  Inhibition of T-cell invasion across cultured fibroblast monolayers by phenothiazine-related calmodulin inhibitors: impairment of lymphocyte motility by trifluoperazine and chlorpromazine, and alteration of the monolayer by pimozide. , 2001, Biochemical pharmacology.

[29]  H. Holmsen,et al.  Chlorpromazine-induced increase in dipalmitoylphosphatidylserine surface area in monolayers at room temperature. , 2001, Biochemical pharmacology.

[30]  S. Tayebati,et al.  Dopamine receptors in human platelets , 2001, Naunyn-Schmiedeberg's Archives of Pharmacology.

[31]  A. Toker,et al.  Antagonists of Calcium Fluxes and Calmodulin Block Activation of the p21-Activated Protein Kinases in Neutrophils1 , 2001, The Journal of Immunology.

[32]  M. Wagner,et al.  Non-benzodiazepines for the treatment of insomnia. , 2000, Sleep medicine reviews.

[33]  H. Holmsen,et al.  The stimulatory effects of cationic amphiphilic drugs on human platelets treated with thrombin. , 2000, Biochemical pharmacology.

[34]  G. Dı́az-Véliz,et al.  Gender, Estrous Cycle, Ovariectomy, and Ovarian Hormones Influence the Effects of Diazepam on Avoidance Conditioning in Rats , 2000, Pharmacology Biochemistry and Behavior.

[35]  J. Stephenson.  Substance Abuse Treatment , 2000 .

[36]  L. Kochan,et al.  Status epilepticus results in an N-methyl-d-aspartate receptor-dependent inhibition of Ca2+/calmodulin-dependent kinase II activity in the rat , 1999, Neuroscience.

[37]  N. Kajimura,et al.  Association between Delta Waves during Sleep and Negative Symptoms in Schizophrenia , 1999, Neuropsychobiology.

[38]  R. Buchanan,et al.  Diazepam treatment of early signs of exacerbation in schizophrenia. , 1999, The American journal of psychiatry.

[39]  Y. Okamoto,et al.  Effect of citalopram on the desensitization of serotonin-2A receptor-mediated calcium mobilization in rat glioma cells , 1996, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[40]  W. Gattaz,et al.  Increased platelet phospholipase A2 activity in schizophrenia , 1995, Schizophrenia Research.

[41]  N. Kajimura,et al.  A quantitative sleep-EEG study on the effects of benzodiazepine and zopiclone in schizophrenic patients , 1995, Schizophrenia Research.

[42]  H. Holmsen,et al.  Diacylglycerol elevations in control platelets are unaccompanied by pleckstrin phosphorylation. Implications for the role of diacylglycerol in platelet activation. , 1995, European journal of biochemistry.

[43]  Jeffrey K. Yao,et al.  Platelet aggregation and dense granule secretion in schizophrenia , 1994, Psychiatry Research.

[44]  Kajimura Naofumi,et al.  Effects of zopiclone on sleep and symptoms in schizophrenia: Comparison with benzodiazepine hypnotics , 1994, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[45]  M. Bickel,et al.  Adipose tissue storage of drugs as a function of binding competition. In‐vitro studies with distribution dialysis , 1994, The Journal of pharmacy and pharmacology.

[46]  C. Martini,et al.  Age-related changes in peripheral benzodiazepine receptors of human platelets. , 1994, Journal of psychiatry & neuroscience : JPN.

[47]  G. Andersen,et al.  Citalopram for post-stroke pathological crying , 1993, The Lancet.

[48]  K. Brøsen,et al.  The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy , 1992, Clinical pharmacology and therapeutics.

[49]  A. Kagey‐Sobotka,et al.  Effect of H1 receptor blockade on the early and late response to cutaneous allergen challenge. , 1992, The Journal of pharmacology and experimental therapeutics.

[50]  O. Lingjaerde.  Benzodiazepines in the treatment of schizophrenia: an updated survey. , 1991, Acta psychiatrica Scandinavica.

[51]  R. Moreno-Sánchez,et al.  Inhibition of substrate oxidation in mitochondria by the peripheral-type benzodiazepine receptor ligand AHN 086. , 1991, Biochemical pharmacology.

[52]  V. Papadopoulos,et al.  Peripheral-type benzodiazepine receptors mediate translocation of cholesterol from outer to inner mitochondrial membranes in adrenocortical cells. , 1990, The Journal of biological chemistry.

[53]  V. Steen,et al.  Evidence that chlorpromazine and prostaglandin E1 but not neomycin interfere with the inositol phospholipid metabolism in intact human platelets , 1990, FEBS letters.

[54]  M. Norenberg,et al.  Diazepam inhibits calcium, calmodulin-dependent protein kinase in primary astorcyte cultures , 1989, Brain Research.

[55]  S. Shumak,et al.  Davidson's Principles and practice of medicine , 1988, The Ulster Medical Journal.

[56]  K. Neftel,et al.  [Benzodiazepine--practice and problems of its use]. , 1988, Schweizerische medizinische Wochenschrift.

[57]  L. Stuhne-Sekalec,et al.  Effect of chlorpromazine on the synthesis, hydrolysis, and transfer of microsomal cytidine liponucleotides and mitochondrial polyglycerophosphatides. , 1987, Canadian journal of physiology and pharmacology.

[58]  D. Greenblatt,et al.  Tissue Distribution of Diazepam and Its Metabolite Desmethyldiazepam: A Human Autopsy Study , 1985, Journal of clinical pharmacology.

[59]  O. Tysnes,et al.  Thin-layer chromatography of polyphosphoinositides from platelet extracts: interference by an unknown phospholipid. , 1985, Thrombosis research.

[60]  C. Dangelmaier,et al.  Differential effects of trifluoperazine on arachidonate liberation, secretion and myosin phosphorylation in intact platelets. , 1984, Thrombosis research.

[61]  Y. Kanaho,et al.  Mechanism of inhibitory effect of some amphiphilic drugs on platelet aggregation induced by collagen, thrombin or arachidonic acid. , 1983, Thrombosis research.

[62]  B. Roufogalis,et al.  Pharmacological antagonism of calmodulin. , 1983, Canadian journal of biochemistry and cell biology = Revue canadienne de biochimie et biologie cellulaire.

[63]  Y. Dudai,et al.  Heterogeneity in the physicochemical properties of deoxycholate-solubilized benzodiazepine receptors from calf cerebral cortex , 1983, Neurochemical Research.

[64]  Y. Dudai,et al.  Diethylpyrocarbonate modification of benzodiazepine receptors from calf cerebral cortex , 1983, Neurochemical Research.

[65]  C. Dangelmaier,et al.  Thrombin-induced platelet responses differ in requirement for receptor occupancy. Evidence for tight coupling of occupancy and compartmentalized phosphatidic acid formation. , 1981, The Journal of biological chemistry.

[66]  H. Holmsen,et al.  Myosin phosphorylation in intact platelets. , 1981, The Journal of biological chemistry.

[67]  D. Hathaway,et al.  Human platelet myosin light chain kinase requires the calcium-binding protein calmodulin for activity. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[68]  J. F. Waller.  Davidson's Principles and Practice of Medicine , 1978 .

[69]  H. Holmsen,et al.  Studies on gel-filtered human platelets: isolation and characterization in a medium containing no added Ca2+, Mg2+, or K+. , 1975, The Journal of laboratory and clinical medicine.

[70]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[71]  H. Nasrallah,et al.  Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles , 2008, Molecular Psychiatry.

[72]  B. Kanchanatawan,et al.  Antipsychotic-induced tardive movement disorders: a series of twelve cases. , 2007, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[73]  I. Lombardo,et al.  Ziprasidone for the Treatment of Acute Manic or Mixed Episodes Associated with Bipolar Disorder , 2007, CNS drugs.

[74]  Tomas Palenicek,et al.  Mechanism of Action of Atypical Antipsychotic Drugs and the Neurobiology of Schizophrenia , 2006, CNS drugs.

[75]  V. Lee,et al.  Ziprasidone: an atypical antipsychotic drug for the treatment of schizophrenia. , 2002, Clinical therapeutics.

[76]  T. Dinan,et al.  Elevated expression of integrin alpha(IIb) beta(IIIa) in drug-naïve, first-episode schizophrenic patients. , 2002, Biological psychiatry.

[77]  加藤 昌明.  Association between delta waves during sleep and negative symptoms in schizophrenia : Pharmaco-EEG studies by using structurally different hypnotics , 2000 .

[78]  C. Martini,et al.  Changes in peripheral benzodiazepine receptors in patients with panic disorder and obsessive-compulsive disorder. , 1994, Neuropsychobiology.

[79]  A. Mclellan,et al.  Substance abuse treatment. , 1994, Hospital & community psychiatry.

[80]  V. Papadopoulos,et al.  Mitochondrial benzodiazepine receptors and the regulation of steroid biosynthesis. , 1992, Annual review of pharmacology and toxicology.

[81]  J. Hirsch,et al.  Mitochondrial benzodiazepine receptors mediate inhibition of mitochondrial respiratory control. , 1989, Molecular pharmacology.

[82]  S. Snyder,et al.  Peripheral type benzodiazepine receptors. , 1989, Annual review of pharmacology and toxicology.

[83]  D. Brindley,et al.  Intracellular translocation of phosphatidate phosphohydrolase and its possible role in the control of glycerolipid synthesis. , 1984, Progress in lipid research.

[84]  D. Greenblatt,et al.  Drug therapy. Current status of benzodiazepines. , 1983, The New England journal of medicine.

[85]  P. Skolnick,et al.  Benzodiazepine receptors in the central nervous system. , 1982, International review of neurobiology.

[86]  Phil Skolniek,et al.  Benzodiazepine receptors in the central nervous system. , 1982 .